Federal Register of Legislation - Australian Government

Primary content

PB 37 of 2014 Determinations/Health as made
This instrument amends the National Health (Price and Special Patient Contribution) Determination 2010 (No. PB 109 of 2010) by removing one listed drug following the deletion of a brand of that drug to which a brand premium had applied.
Administered by: Health
Made 12 May 2014
Registered 21 May 2014
Tabled HR 26 May 2014
Tabled Senate 16 Jun 2014
Date of repeal 02 Jun 2014
Repealed by Division 1 of Part 5A of the Legislative Instruments Act 2003

 

PB 37 of 2014

National Health (Price and Special Patient Contribution) Amendment Determination 2014 (No. 4)

National Health Act 1953

I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated 12 May 2014

 

 

 

 

 

 

 

 

 

FELICITY McNEILL

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health


 


1          Name of Instrument

            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2014 (No. 4).

            (2)        This Instrument may also be cited as PB 37 of 2014.

2          Commencement

            This Instrument commences on 1 June 2014.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).



Schedule 1     Amendments

 

[1] Schedule 1, omit entry for Gemfibrozil